Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAIS Mites SLIT in Elderly Patients with HDM Allergy
NCT02277483Phase 4Unknown
- Sponsor
- Ajou University School of Medicine
- Start
- Oct 2014
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in allergic rhinoconjunctivitis (ARC) (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Total Combined Score at 48 weeks. Status: unknown.
02
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT02277483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02277483.